Clinical Trials Logo

Clinical Trial Summary

The aim of the study is to investigate whether Low Dose Aspirin and Low Molecular Weight Heparin could increase the uterine perfusion, and finally improve the implantation and pregnancy rates in patients with unexplained recurrent implantation failure.


Clinical Trial Description

Infertility is a growing issue for many couples all over the world. Nowadays, Assisted reproductive technology is widely used to treat couples affected by infertility, but, the success rate is still very low. Recurrent implantation failure is an important cause of repeated IVF failure. In addition to the embryo quality, a functioning and receptive endometrium is crucial for embryo implantation. There is a growing amount of evidence shows that uterine perfusion playing an important part in regulating endometrial receptivity and in successful pregnancy.

Recently, transvaginal ultrasonography is often used to examine endometrial thickness, pattern and blood flow status to predict uterine receptivity. Some studies have demonstrated that uterine artery blood flow resistance in RM (Recurrent miscarriage) patients is significantly higher than in normal fertile patients. It has been postulated that abnormal uterine perfusion could be related to the reproductive failure, enhancing the uterine perfusion may improve the successful pregnancy. In accordance with this hypothesis, some therapeutic approaches including low dose aspirin (LDA), nitric oxide donor, low molecular weight heparin, sildenafil are applying in clinic. Low molecular weight heparin (LMWH) is derived from unfractionated heparin. It also has anticoagulation or the antithrombin effect. Aspirin has analgesic, antipyretic, and anti-inflammatory properties. Initially, aspirin and low molecular weight heparin have been used either as single agents or in combination to treat patients with recurrent miscarriage, diagnosed with antiphospholipid syndrome. The treatment confers a significant benefit in live births rate. Furthermore, various studies have shown that thrombophilia are more common in women with RIF compared with healthy fertile controls. In these women, heparin treatment could potentially enhance the implantation process, and may finally improve the live birth rate. The aim of the study is to investigate whether Low Dose Aspirin and Low Molecular Weight Heparin could increase the uterine perfusion, and finally improve the implantation and pregnancy rates in patients with unexplained recurrent implantation failure. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03365466
Study type Observational
Source Shanghai First Maternity and Infant Hospital
Contact Shihua Bao, PhD
Phone 86-21-20261430
Email baoshihua@tongji.edu.cn
Status Not yet recruiting
Phase N/A
Start date December 2017
Completion date February 2019

See also
  Status Clinical Trial Phase
Recruiting NCT03660735 - The PIP Study - Pre- IVF Immune Profiling Study
Not yet recruiting NCT04528277 - Short Course Rifapentine and Isoniazid for the Preventive Treatment for Latent Genital Tuberculosis Phase 3
Recruiting NCT04998279 - Intrauterine Infusion of GCSF and Reproductive Outcomes in Infertile Women With History of RIF
Completed NCT03267797 - hCG-activated PBMC-therapy in RIF Patients N/A
Recruiting NCT04118959 - Role of Atosiban in Recurrent Implantation Failure
Recruiting NCT05343572 - Bone Marrow Derived Stem Cells Mobilization for Treatment of Abnormal Endometrium Early Phase 1
Not yet recruiting NCT02752568 - Assisted Hatching Versus Endometrial Scratch in Recurrent Implantation Failure N/A
Recruiting NCT04822207 - Effect of Acupuncture on the Clinical Outcome of IVF-ET in Patients With Recurrent Implantation Failure N/A
Recruiting NCT03900780 - Preimplantation Genetic Testing for Aneuploidies in Patients With Recurrent Implantation Failure N/A
Not yet recruiting NCT03549728 - Effect of Granulocyte Colony-stimulating Factor on Clinical Pregnancy Rate in Patients With Endometriosis Phase 2
Completed NCT03174964 - Immunomodulatory Effects of IVIg on Pregnancy Rate of Patient With Recurrent Implantation Failure Phase 2
Completed NCT03161340 - Immunomodulatory Effects of Rapamycin on Pregnancy Rate of Patient With Recurrent Implantation Failure Phase 2
Not yet recruiting NCT01278706 - Endometrial Biopsy Protocol for In Vitro Fertilization (IVF) N/A
Completed NCT00750451 - Low Molecular Weight Heparin in Recurrent Implantation Failure N/A
Not yet recruiting NCT03690830 - Use of Metabolomics for the Identification of Endometrial Biomarkers for IRPL and RIF After in Vitro Fertilization N/A
Not yet recruiting NCT03355937 - Using Microfluidic Separation Sperm Selection for Unexplained Infertility and Reccurrent Implantation Failure N/A
Recruiting NCT05169541 - Association Between Plasma Level of Mannose Binding Lectin and Human Reproduction
Completed NCT04085783 - PRP in Recurrent Implantation Failure N/A
Active, not recruiting NCT03421639 - Aromatase Plus GnRH Analogue Versus GnRH Analog Alone in Adenomyosis Phase 4
Recruiting NCT04293068 - Effect of Reproductive Tract Microbiota on Pregnancy Outcome in IVF/ICSI